Abstract
Patients with chronic heart failure have prolonged sympathetic stimulation and subsequent worsening of the failing heart function. Beta-blockers (non-selective, cardio-selective, and non-selective with ancillary properties) counteract the effects of prolonged sympathetic stimulation. Beta-blocker therapy results in the improvement of the left ventricular systolic and diastolic function, reversal remodeling, heart rate control, effective prevention of the malignant arrhythmias, and lowering of the both cardiac afterload and preload in patients with chronic heart failure.
Keywords: Beta-blockers, mechanisms, childhood, heart failure.
Reviews on Recent Clinical Trials
Title:Mechanisms of Beta-Blockers Action in Patients with Heart Failure
Volume: 9 Issue: 2
Author(s): Sergej Prijic and Reiner Buchhorn
Affiliation:
Keywords: Beta-blockers, mechanisms, childhood, heart failure.
Abstract: Patients with chronic heart failure have prolonged sympathetic stimulation and subsequent worsening of the failing heart function. Beta-blockers (non-selective, cardio-selective, and non-selective with ancillary properties) counteract the effects of prolonged sympathetic stimulation. Beta-blocker therapy results in the improvement of the left ventricular systolic and diastolic function, reversal remodeling, heart rate control, effective prevention of the malignant arrhythmias, and lowering of the both cardiac afterload and preload in patients with chronic heart failure.
Export Options
About this article
Cite this article as:
Prijic Sergej and Buchhorn Reiner, Mechanisms of Beta-Blockers Action in Patients with Heart Failure, Reviews on Recent Clinical Trials 2014; 9 (2) . https://dx.doi.org/10.2174/1574887109666140908125402
DOI https://dx.doi.org/10.2174/1574887109666140908125402 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nicotine Addiction and Coronary Artery Disease: Impact of Cessation Interventions
Current Pharmaceutical Design The Role of Colchicine in Pericardial Syndromes
Current Pharmaceutical Design Obstetric Anaesthesia and Obesity
Current Women`s Health Reviews EGFR and the Complexity of Receptor Crosstalk in the Cardiovascular System
Current Molecular Medicine Most Efficient Routes for the Synthesis of α,β-Diamino Acid-Derived Compounds
Current Pharmaceutical Design The Discovery and Development of Drug Combinations for the Treatment of Various Diseases from Patent Literature (1980-Present)
Current Topics in Medicinal Chemistry Defective Autophagy in Fibroblasts May Contribute to Fibrogenesis in Autoimmune Processes
Current Pharmaceutical Design Techniques to Investigate Neuronal Mitochondrial Function and its Pharmacological Modulation
Current Drug Targets Rheumatoid Arthritis, Immunosenescence and the Hallmarks of Aging
Current Aging Science Ischemic Colitis: Current Diagnosis and Treatment
Current Drug Targets Editorial (Thematic Issue: Advances in The Therapy of Atrial Fibrillation: Incrementally Progressive But Not Without Missteps)
Current Cardiology Reviews Fibrates in the Chemical Action of Daunorubicin
Current Cancer Drug Targets Reversal of Cardiac Iron Loading and Dysfunction in Thalassemic Mice by Curcuminoids
Medicinal Chemistry Drug Metabolism and Pharmacokinetic Diversity of Ranunculaceae Medicinal Compounds
Current Drug Metabolism Introduction: P2 Receptors
Current Topics in Medicinal Chemistry LFA-1 as a Key Regulator of Immune Function: Approaches toward the Development of LFA-1-Based Therapeutics
Current Pharmaceutical Design The Utility of Metformin Therapy in Reproductive-Aged Women with Polycystic Ovary Syndrome (PCOS)
Current Pharmaceutical Biotechnology Anti-proliferative Properties of miR-20b and miR-363 from the miR-106a-363 Cluster on Human Carcinoma Cells
MicroRNA Cocaine and Acute Vascular Diseases
Current Drug Abuse Reviews Susceptibility Genes in Hypertension
Current Pharmaceutical Design